BACKGROUND: Bariatric surgery is the most effective weight loss treatment, yet few studies have reported on short- and long-term outcomes postsurgery. METHODS: Using claims data from seven Blue Cross/Blue Shield health plans serving seven states, we conducted a non-concurrent, matched cohort study. We followed 22,693 persons who underwent bariatric surgery during 2003-2007 and were enrolled at least 6 months before and after surgery. Using logistic regression, we compared serious and less serious adverse clinical outcomes, hospitalizations, planned procedures, and obesity-related co-morbidities between groups for up to 5 years. RESULTS: Relative to controls, surgery patients were more likely to experience a serious [odds ratio (OR) 1.9; 95% confidence interval (CI) 1.8-2.0] or less serious (OR 2.5, CI 2.4-2.7) adverse clinical outcome or hospitalization (OR 1.3, CI 1.3-1.4) at 1 year postsurgery. The risk remained elevated until 4 years postsurgery for serious events and 5 years for less serious outcomes and hospitalizations. Some complication rates were lower for patients undergoing laparoscopic surgery. Planned procedures, such as skin reduction, peaked in postsurgery year 2 but remained elevated through year 5. Surgery patients had a 55% decreased risk of obesity-related co-morbidities, such as type 2 diabetes, in the first year postsurgery, which remained low throughout the study (year 5: OR 0.4, CI 0.4-0.5). CONCLUSIONS: While bariatric surgery is associated with a higher risk of adverse clinical outcomes compared to controls, it also substantially decreased obesity-related co-morbidities during the 5-year follow-up.
BACKGROUND: Bariatric surgery is the most effective weight loss treatment, yet few studies have reported on short- and long-term outcomes postsurgery. METHODS: Using claims data from seven Blue Cross/Blue Shield health plans serving seven states, we conducted a non-concurrent, matched cohort study. We followed 22,693 persons who underwent bariatric surgery during 2003-2007 and were enrolled at least 6 months before and after surgery. Using logistic regression, we compared serious and less serious adverse clinical outcomes, hospitalizations, planned procedures, and obesity-related co-morbidities between groups for up to 5 years. RESULTS: Relative to controls, surgery patients were more likely to experience a serious [odds ratio (OR) 1.9; 95% confidence interval (CI) 1.8-2.0] or less serious (OR 2.5, CI 2.4-2.7) adverse clinical outcome or hospitalization (OR 1.3, CI 1.3-1.4) at 1 year postsurgery. The risk remained elevated until 4 years postsurgery for serious events and 5 years for less serious outcomes and hospitalizations. Some complication rates were lower for patients undergoing laparoscopic surgery. Planned procedures, such as skin reduction, peaked in postsurgery year 2 but remained elevated through year 5. Surgery patients had a 55% decreased risk of obesity-related co-morbidities, such as type 2 diabetes, in the first year postsurgery, which remained low throughout the study (year 5: OR 0.4, CI 0.4-0.5). CONCLUSIONS: While bariatric surgery is associated with a higher risk of adverse clinical outcomes compared to controls, it also substantially decreased obesity-related co-morbidities during the 5-year follow-up.
Authors: L D George Angus; Daniel R Cottam; Piotr J Gorecki; Ramon Mourello; Raul E Ortega; John Adamski Journal: Obes Surg Date: 2003-08 Impact factor: 4.129
Authors: Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean Journal: Ann Surg Date: 2004-09 Impact factor: 12.969
Authors: Jerome H Liu; David Zingmond; David A Etzioni; Jessica B O'Connell; Melinda A Maggard; Edward H Livingston; Carson D Liu; Clifford Y Ko Journal: Am Surg Date: 2003-10 Impact factor: 0.688
Authors: Scott F Gallagher; Magdalena Banasiak; John P Gonzalvo; Daniel P Paoli; Janice Allwood; Debra Morris; Michel M Murr; David H Shapiro Journal: Obes Surg Date: 2003-04 Impact factor: 4.129
Authors: Robert N Cooney; Randy S Haluck; James Ku; Thomas Bass; Janelle MacLeod; Heather Brunner; Cynthia A Miller Journal: Obes Surg Date: 2003-02 Impact factor: 4.129
Authors: Luigi Schiavo; Giuseppe Scalera; Vincenzo Pilone; Gabriele De Sena; Antonio Iannelli; Alfonso Barbarisi Journal: Obes Surg Date: 2017-04 Impact factor: 4.129
Authors: D Val-Laillet; E Aarts; B Weber; M Ferrari; V Quaresima; L E Stoeckel; M Alonso-Alonso; M Audette; C H Malbert; E Stice Journal: Neuroimage Clin Date: 2015-03-24 Impact factor: 4.881
Authors: Edward W Gregg; Haiying Chen; Lynne E Wagenknecht; Jeanne M Clark; Linda M Delahanty; John Bantle; Henry J Pownall; Karen C Johnson; Monika M Safford; Abbas E Kitabchi; F Xavier Pi-Sunyer; Rena R Wing; Alain G Bertoni Journal: JAMA Date: 2012-12-19 Impact factor: 56.272
Authors: Steven H Belle; Paul D Berk; William H Chapman; Nicholas J Christian; Anita P Courcoulas; Greg F Dakin; David R Flum; Mary Horlick; Wendy C King; Carol A McCloskey; James E Mitchell; Emma J Patterson; John R Pender; Kristine J Steffen; Richard C Thirlby; Bruce M Wolfe; Susan Z Yanovski Journal: Surg Obes Relat Dis Date: 2013-03-07 Impact factor: 4.734
Authors: Anita Courcoulas; R Yates Coley; Jeanne M Clark; Corrigan L McBride; Elizabeth Cirelli; Kathleen McTigue; David Arterburn; Karen J Coleman; Robert Wellman; Jane Anau; Sengwee Toh; Cheri D Janning; Andrea J Cook; Neely Williams; Jessica L Sturtevant; Casie Horgan; Ali Tavakkoli Journal: JAMA Surg Date: 2020-03-01 Impact factor: 14.766